NVCT

Nuvectis Pharma, Inc.

Healthcare · Biotechnology

$126.41 sample

-1.20 (-0.94%) 1D

Market cap

$580.9B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-15

Alerts

8

Price$126.41 -3.90% 3M daily closessample

133.69125.38

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 07INSInsider sell: 10% owner
Sep 29INSInsider sell: Chief Financial Officer
Sep 21INSInsider buy: EVP, Operations
Sep 15SECDEF 14A filed
Sep 08SEC10-Q filed
Sep 01INSInsider sell: Chief Financial Officer
Aug 26SECDEF 14A filed
Aug 17INSInsider sell: EVP, Operations

Sign up to see the real NVCT record →

Company facts

SEC EDGAR registration

Name: Nuvectis Pharma, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -31sample, -100 to +100
Reporting currency: USD

Who is positioning in NVCT

sample

Insiders: 7 insider transactions over 90 days, net selling, $400.0M
Congress: 4 members traded over 90 days
Institutions · 13F: 22 funds hold $8.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$21.1B +12.2% y/y

Q4 2024Q3 2026

Inventory$12.9B +9.7% y/y

Q4 2024Q3 2026

Accounts receivable$9.2B +5.0% y/y

Q4 2024Q3 2026

Total debt$24.1B +9.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $85.9B -4.5% 3M
Sample peer B: $407.6B +3.6% 3M
Sample peer C: $337.7B +5.7% 3M
Sample peer D: $185.2B -4.7% 3M
Sample peer E: $204.8B +8.3% 3M